US FDA approves second indication for Skyrizi to treat adults with active psoriatic arthritis
Skyrizi maintains a dosing regimen for PsA that is consistent with the existing regimen for moderate-to-severe plaque psoriasis…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.